Malicious PyPI packages give hackers control of Telegram bot servers

A campaign active since last November has been targeting Python developers building Telegram bots with trojanized Pyrogram ...

'Just icky'. Florida hunter cracks open a python egg on video

Professional python hunter Amy Siewe recently posted a video on her Facebook page showing her cutting open a snake's egg to see what it looks like.
The American Journal of Managed Care

FDA Issues Complete Response Letter for Cingulate's Once-Daily ADHD Drug CTx-1301

FDA feedback centered on CMC documentation and quality/manufacturing controls, a common first-cycle barrier that typically does not necessitate additional efficacy or safety trials. Pediatric ...
Investopedia

Corporate Trade Exchange (CTX): What It Is and How It Works

Carol M. Kopp edits features on a wide range of subjects for Investopedia, including investing, personal finance, retirement planning, taxes, business management, and career development. Investopedia ...
Nasdaq

Cingulate Presents Positive Phase 3 Results for CTx-1301 Demonstrating Statistically Significant Efficacy and Entire Active-Day Symptom Control

Once-daily formulation of dexmethylphenidate achieved primary endpoint (p 0.001) with consistent symptom relief up to 12 hours post-dose KANSAS CITY, Kan., Oct. 28, 2025 (GLOBE NEWSWIRE) -- Cingulate ...
Nasdaq

Cingulate Submits New Drug Application to FDA for Lead ADHD Asset CTx-1301

KANSAS CITY, Kan., Aug. 06, 2025 (GLOBE NEWSWIRE) -- Cingulate Inc. (NASDAQ: CING), a biopharmaceutical company utilizing its proprietary Precision Timed Release™ (PTR™) drug delivery platform ...
ascopubs.org

Tarlatamab versus chemotherapy (CTx) as second-line (2L) treatment for small cell lung cancer (SCLC): Primary analysis of Ph3 DeLLphi-304.

Randomized phase II trial investigating whether atezolizumab after chemoradiotherapy (CRT) prolongs survival in limited stage (LS) small cell lung cancer (SCLC). Perioperative nivolumab (NIVO) vs ...
Yahoo Finance

Cingulate Announces Positive Top-Line Results from High-Dose (50mg) Fed/Fast Study of Lead Asset CTx-1301 for ADHD

KANSAS CITY, Kan., April 29, 2025 (GLOBE NEWSWIRE) -- Cingulate Inc. (NASDAQ: CING), a biopharmaceutical company utilizing its proprietary Precision Timed Release™ (PTR™) drug delivery platform ...
PMLiVE

FDA approves Mirum’s Ctexli as first treatment for rare lipid storage disease CTX

The US Food and Drug Administration (FDA) has approved Mirum Pharmaceuticals’ Ctexli (chenodiol) to treat adults with cerebrotendinous xanthomatosis (CTX). The oral drug is now the first treatment to ...
pharmaphorum

FDA clears first therapy for rare disease CTX from Mirum

Mirum Pharma's Ctexli has become the first FDA-approved therapy for cerebrotendinous xanthomatosis (CTX), an ultra-rare form of lipid storage disease. Ctexli (chenodiol) has been cleared to treat ...
Pharmaceutical Technology

CTX-112 by CRISPR Therapeutics for B-Cell Chronic Lymphocytic Leukemia: Likelihood of Approval

GlobalData tracks drug-specific phase transition and likelihood of approval scores, in addition to indication benchmarks based off 18 years of historical drug development data. Attributes of the drug, ...